MétaCan
Menu
← Back to cohort
Record W6949579781 · doi:10.5281/zenodo.16574828

Perspectives and Insights on Anti-Psoriatic Drugs (D05): From Development to New Drug Submission (NDS) Application to Health Canada

2025· article· en· W6949579781 on OpenAlexaboutno aff

Bibliographic record

VenueZenodo (CERN European Organization for Nuclear Research) · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicPsoriasis: Treatment and Pathogenesis
Canadian institutionsnot available
Fundersnot available
KeywordsReimbursementDrugBiosimilarDrug developmentQuality (philosophy)Drug approvalBiological drugsAccess to medicines

Abstract

fetched live from OpenAlex

Psoriasis, a chronic autoimmune skin disorder, affects millions in Canada, causing erythematous plaques, reduced quality of life, and comorbidities like psoriatic arthritis. Anti-psoriatic drugs (ATC code D05) encompass topical, oral, and biologic therapies targeting inflammatory pathways, such as IL-23/Th17, to manage moderate-to-severe disease. These include traditional systemic agents, targeted small molecules, and biologics, offering diverse mechanisms to balance efficacy and safety. This article reviews the D05 class’s clinical applications, chemical properties, container closure systems, safety profiles, and emerging technologies, such as nanomedicines and precision medicine. It also outlines the regulatory pathway for New Drug Submission (NDS) in Canada, aligning with the Food and Drugs Act, Health Canada regulations, and International Council for Harmonisation (ICH) guidelines. Recommendations address reimbursement barriers, emphasizing early regulatory engagement, robust pharmacovigilance, and equitable access strategies to ensure patient access to innovative therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.026
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.285
Threshold uncertainty score0.573

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.026
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.003
Science and technology studies0.0050.007
Scholarly communication0.0160.005
Open science0.0030.004
Research integrity0.0060.009
Insufficient payload (model declined to judge)0.0270.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.231
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueZenodo (CERN European Organization for Nuclear Research)→Same topicPsoriasis: Treatment and Pathogenesis→French-language works237,207→